Dr V Mohan Awarded for Distinguished International Service in the Cause of Diabetes
IMT News Desk
Dr Viswanathan Mohan, received the American Diabetes Association's® (ADA's) 2018 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes. Dr. V. Mohan is the Chairman and Chief of Diabetology at Dr. Mohan’s Diabetes Specialities Centre at Chennai in South India which is a WHO Collaborating Centre for Noncommunicable Diseases Prevention and Control and IDF Centre of Education. He is also
President and Director of the Madras Diabetes Research Foundation.
Internationally renowned, Dr. Mohan has worked tirelessly to address the challenges of diabetes in India and developing countries. He is actively involved in Indian Government health policy and advocacy programs related to diabetes, and he has served as President of the Research Society for the Study of Diabetes in India. Dr. Mohan’s comprehensive diabetes center boasts 40 branches with computerized clinical data on more than 400,000 patients.
“Thank you, Dr. Mohan, for your commitment to serving people with diabetes and to bringing systematic changes to improve populations. Congratulations on this accomplishment,” said the ADA’s 2018 President of Health Care and Education Felicia Hill-Briggs, PhD, ABPP. “Your efforts to ensure that the best diabetes care is available to people in India and other developing countries have improved millions of lives.”
With several productive international research collaborations, Dr. Mohan has contributed to more than 700 original publications. His remarkable reach in training health care providers includes efforts supported by the World Diabetes Foundation (Denmark) and Public Health Foundation of India, through which he has trained more than 20,000 providers in India, Kenya, Tanzania, Nigeria, Uganda, Cambodia, Vietnam, Bhutan, Sri Lanka and Nepal. He also provides lifelong, free treatment to thousands of patients.
The American Diabetes Association’s 78th Scientific Sessions, was held on June 22-26, 2018, at the Orange County Convention Center in Orlando, is the world’s largest scientific meeting focused on diabetes research, prevention and care.